GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » Capex-to-Revenue

Glow LifeTech (XCNQ:GLOW) Capex-to-Revenue : 0.00 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Glow LifeTech's Capital Expenditure for the three months ended in Sep. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Sep. 2023 was C$0.02 Mil.

Hence, Glow LifeTech's Capex-to-Revenue for the three months ended in Sep. 2023 was 0.00.


Glow LifeTech Capex-to-Revenue Historical Data

The historical data trend for Glow LifeTech's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech Capex-to-Revenue Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Capex-to-Revenue
- - - -

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Glow LifeTech's Capex-to-Revenue

For the Biotechnology subindustry, Glow LifeTech's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glow LifeTech's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's Capex-to-Revenue falls into.



Glow LifeTech Capex-to-Revenue Calculation

Glow LifeTech's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.062) / 0
=N/A

Glow LifeTech's Capex-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.019
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech  (XCNQ:GLOW) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Glow LifeTech Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines